Drugmaker Deals Are Near Record Pace in 2019, but Investors Don’t Love Them All. AbbVie Inc, ALLERGAN INC, Bristol Myers Squibb Company, Celgene Corporation, Mergers, Acquisitions and Divestitures, Humira (Drug), Drugs (Pharmaceuticals), Inventions and Patents, Stocks and Bonds